Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lidocaine Intraoperative Infusion on Postoperative Renal Function in Partial Nephrectomy
ChiCTR2200055935Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in renal cell carcinoma (RCC) and Nephroma (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Estimated glomerular filtration rate (eGFR), Blood urea nitrogen (BUN) and 1 more. Started Dec 2021; status: recruiting.
02
Drugs
lidocaine
03
Conditions
renal cell carcinoma (RCC)Nephroma
Beyond the preview
Go deeper on ChiCTR2200055935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055935.